pre-update Archives

On-Demand Webinar

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…

CertaraJanuary 24, 2024

Blog

Understanding the Role of Your Discovery Asset’s Target Product Profile

If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…

CertaraJanuary 19, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Publication

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…

CertaraJanuary 17, 2024

On-Demand Webinar

Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission

Join our webinar to explore best practices for harnessing the power of standards, without a…

CertaraJanuary 16, 2024

Publication

Real-world application of PBPK in drug discovery

The utility of PBPK models in support of drug development has been well documented. During…

CertaraJanuary 11, 2024

On-Demand Webinar

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

What does it take to industrialize QSP? What is the right mix of technology and…

CertaraJanuary 9, 2024

Fact Sheet

Moving from Molecule to Market

CertaraJanuary 5, 2024

Press Coverage

MedCity News | How the IRA Has Created a New Environment for Biosimilars

By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…

CertaraJanuary 5, 2024

Press Coverage

Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024

By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…

CertaraJanuary 5, 2024

pre-update

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Understanding the Role of Your Discovery Asset’s Target Product Profile

Streamlining Your NCA Workflow

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission

Real-world application of PBPK in drug discovery

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

Moving from Molecule to Market

MedCity News | How the IRA Has Created a New Environment for Biosimilars

Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024

Newsletter sign up

Quick links

Solutions

Contact